Fluocinonide

Fluocinonide
Clinical data
Trade names	Fluonex, Lidex, others
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a601054
Routes of; administration	Topical
ATC code	C05AA11(WHO)D07AC08(WHO),QC05AA11(WHO),QD07AC08(WHO);
Legal status
Legal status	AU:S4(Prescription only); UK:POM(Prescription only); US:WARNINGRx-only;
Pharmacokineticdata
Metabolism	Liver
Identifiers
	IUPAC name 6α,9-difluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,21-acetate;
CAS Number	356-12-7;
PubChemCID	9642;
IUPHAR/BPS	7078;
DrugBank	DB01047;
ChemSpider	9265;
UNII	2W4A77YPAN;
KEGG	D00325;
ChEMBL	ChEMBL1501;
CompTox Dashboard(EPA)	DTXSID8045307;
ECHA InfoCard	100.005.998
Chemical and physical data
Formula	C26H32F2O7
Molar mass	494.532g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC(=O)[C@]45OC(O[C@@H]5C[C@@H]2[C@@]4(C[C@H](O)[C@]3(F)[C@]/1(/C=C\C(=O)\C=C\1[C@@H](F)C[C@@H]23)C)C)(C)C)C;
	InChI InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1; Key:WJOHZNCJWYWUJD-IUGZLZTKSA-N;
	(verify)

Fluocinonideis a potentglucocorticoidusedtopicallyas ananti-inflammatoryagent for the treatment ofskin disorderssuch aseczemaandseborrhoeic dermatitis.^[3]It relievesitching,redness,dryness,crusting, scaling,inflammation,and discomfort.^[3]

A common potential adverse effect is skin atrophy (thinning of the skin).^[4]

In 2021, it was the 249th most commonly prescribed medication in the United States, with more than 1million prescriptions.^[5]^[6]

Veterinary uses

Fluocinonide is used in veterinary medicine. It is a treatment for allergies in dogs.^[7]Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure.^[8]

References

^"Fluocinonide Topical".MedlinePlus Drug Information.U.S. National Library of Medicine.
^"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)".nctr-crs.fda.gov.FDA.Retrieved22 October2023.
^^a ^b"Fluocinonide Topical: MedlinePlus Drug Information".medlineplus.gov.Retrieved16 November2022.
^Jablonska S, Groniowska M, Dabroswki J (February 1979). "Comparative evaluation of skin atrophy in man induced by topical corticoids".The British Journal of Dermatology.100(2): 193–206.doi:10.1111/j.1365-2133.1979.tb05561.x.PMID 154921.S2CID 30656827.
^"The Top 300 of 2021".ClinCalc.Archivedfrom the original on 15 January 2024.Retrieved14 January2024.
^"Fluocinonide - Drug Usage Statistics".ClinCalc.Retrieved14 January2024.
^Dog Allergies.Squidoo(Report).
^Zenoble RD, Kemppainen RJ (September 1987). "Adrenocortical suppression by topically applied corticosteroids in healthy dogs".Journal of the American Veterinary Medical Association.191(6): 685–688.PMID 2824410.

[1] "Fluocinonide Topical".MedlinePlus Drug Information.U.S. National Library of Medicine.

[FDA-AllBoxedWarnings-2] "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)".nctr-crs.fda.gov.FDA.Retrieved22 October2023.

[:1-3] "Fluocinonide Topical: MedlinePlus Drug Information".medlineplus.gov.Retrieved16 November2022.

[:0-4] Jablonska S, Groniowska M, Dabroswki J (February 1979). "Comparative evaluation of skin atrophy in man induced by topical corticoids".The British Journal of Dermatology.100(2): 193–206.doi:10.1111/j.1365-2133.1979.tb05561.x.PMID 154921.S2CID 30656827.

[5] "The Top 300 of 2021".ClinCalc.Archivedfrom the original on 15 January 2024.Retrieved14 January2024.

[6] "Fluocinonide - Drug Usage Statistics".ClinCalc.Retrieved14 January2024.

[7] Dog Allergies.Squidoo(Report).

[8] Zenoble RD, Kemppainen RJ (September 1987). "Adrenocortical suppression by topically applied corticosteroids in healthy dogs".Journal of the American Veterinary Medical Association.191(6): 685–688.PMID 2824410.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]